Jilin Aodong Pharmaceutical Group Co., Ltd. (SHE:000623)
China
· Delayed Price · Currency is CNY 16.27
-0.35 (-2.11%)
Feb 28, 2025, 2:45 PM CST
SHE:000623 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Feb '25 Feb 27, 2025 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 19,481 | 17,098 | 17,020 | 21,034 | 18,957 | 19,225 | Upgrade
|
| Market Cap Growth | 6.55% | 0.46% | -19.09% | 10.96% | -1.39% | 14.58% | Upgrade
|
| Enterprise Value | 18,954 | 16,961 | 17,193 | 19,596 | 17,652 | 18,823 | Upgrade
|
| Last Close Price | 16.29 | 14.30 | 13.89 | 16.78 | 14.77 | 14.66 | Upgrade
|
| PE Ratio | 13.29 | 11.71 | 9.56 | 11.81 | 11.09 | 13.70 | Upgrade
|
| PS Ratio | 6.29 | 4.96 | 5.93 | 9.13 | 8.42 | 6.22 | Upgrade
|
| PB Ratio | 0.67 | 0.62 | 0.65 | 0.84 | 0.81 | 0.86 | Upgrade
|
| P/TBV Ratio | 0.73 | 0.64 | 0.66 | 0.86 | 0.82 | 0.88 | Upgrade
|
| P/FCF Ratio | - | - | 111.32 | 1821.95 | 116.28 | 122.40 | Upgrade
|
| P/OCF Ratio | 67.70 | 251.22 | 40.15 | 64.75 | 48.56 | 50.66 | Upgrade
|
| EV/Sales Ratio | 6.31 | 4.92 | 5.99 | 8.51 | 7.84 | 6.09 | Upgrade
|
| EV/EBITDA Ratio | 133.98 | 50.08 | 52.66 | 97.79 | 136.07 | 51.20 | Upgrade
|
| EV/EBIT Ratio | - | 126.08 | 132.35 | 3339.39 | - | 108.40 | Upgrade
|
| EV/FCF Ratio | -255.30 | - | 112.45 | 1697.40 | 108.28 | 119.85 | Upgrade
|
| Debt / Equity Ratio | 0.07 | 0.11 | 0.11 | 0.10 | 0.11 | 0.09 | Upgrade
|
| Debt / EBITDA Ratio | 15.40 | 8.26 | 8.41 | 12.45 | 19.13 | 5.69 | Upgrade
|
| Debt / FCF Ratio | - | - | 19.56 | 226.58 | 15.22 | 13.33 | Upgrade
|
| Asset Turnover | 0.09 | 0.11 | 0.10 | 0.08 | 0.08 | 0.12 | Upgrade
|
| Inventory Turnover | 1.82 | 2.02 | 1.93 | 1.95 | 1.70 | 1.79 | Upgrade
|
| Quick Ratio | 1.77 | 1.08 | 2.25 | 3.89 | 4.01 | 5.59 | Upgrade
|
| Current Ratio | 2.24 | 1.29 | 2.70 | 4.35 | 4.47 | 6.19 | Upgrade
|
| Return on Equity (ROE) | 4.92% | 5.37% | 7.01% | 7.29% | 7.36% | 6.38% | Upgrade
|
| Return on Assets (ROA) | -0.19% | 0.27% | 0.27% | 0.01% | -0.15% | 0.43% | Upgrade
|
| Return on Capital (ROIC) | -0.20% | 0.28% | 0.28% | 0.01% | -0.16% | 0.45% | Upgrade
|
| Return on Capital Employed (ROCE) | - | 0.48% | 0.45% | 0.02% | - | 0.70% | Upgrade
|
| Earnings Yield | 7.34% | 8.54% | 10.46% | 8.46% | 9.01% | 7.30% | Upgrade
|
| FCF Yield | -0.38% | -2.06% | 0.90% | 0.05% | 0.86% | 0.82% | Upgrade
|
| Dividend Yield | 2.41% | 4.20% | 2.16% | 1.79% | 1.35% | 1.36% | Upgrade
|
| Payout Ratio | 57.34% | 27.44% | 21.21% | 14.36% | 14.76% | 17.16% | Upgrade
|
| Buyback Yield / Dilution | 3.73% | 0.46% | -3.36% | 1.39% | 0.28% | -10.06% | Upgrade
|
| Total Shareholder Return | 6.14% | 4.66% | -1.20% | 3.17% | 1.63% | -8.70% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.